Literature DB >> 22744709

Extraperitoneal response to intraperitoneal immunotherapy with catumaxomab in a patient with cutaneous lymphangiosis carcinomatosa from ovarian cancer: a case report and review of the literature.

H Woopen1, K Pietzner, S Darb-Esfahani, G Oskay-Oezcelik, J Sehouli.   

Abstract

Cutaneous metastasation is a very rare manifestation of ovarian cancer. We present the case of a 64-year-old woman with recurrent platinum-refractory ovarian cancer and skin metastasis. The patient was treated with intraperitoneal catumaxomab due to massive refractory malignant ascites. Clinical response of the skin metastasis was observed during the intraperitoneal treatment with catumaxomab. Even though response of extraperitoneal tumor sites can be explained with intravascular uptake and a possible vaccination effect, this phenomenon has not been reported up to this point to the best of our knowledge.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22744709     DOI: 10.1007/s12032-012-0285-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  29 in total

1.  Subcutaneous metastasis from an ovarian carcinoma disappeared following tamoxifen therapy.

Authors:  F Flam; L Skoog; N Wilking
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1996-02       Impact factor: 2.435

2.  Immunomonitoring results of a phase II/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3).

Authors:  Michael Jäger; Alexandra Schoberth; Peter Ruf; Juergen Hess; Michael Hennig; Barbara Schmalfeldt; Pauline Wimberger; Michael Ströhlein; Bettina Theissen; Markus M Heiss; Horst Lindhofer
Journal:  Cancer Res       Date:  2011-11-01       Impact factor: 12.701

Review 3.  The biology of the 17-1A antigen (Ep-CAM).

Authors:  M Balzar; M J Winter; C J de Boer; S V Litvinov
Journal:  J Mol Med (Berl)       Date:  1999-10       Impact factor: 4.599

4.  Influence of catumaxomab on tumor cells in bone marrow and blood in ovarian cancer.

Authors:  P Wimberger; M Heubner; H Lindhofer; M Jäger; R Kimmig; S Kasimir-Bauer
Journal:  Anticancer Res       Date:  2009-05       Impact factor: 2.480

Review 5.  Palliative radiotherapy for the skin metastasis of ovarian cancer: a case report and review of the literature.

Authors:  Senem Demirci; Fatma Yavas; Zeynep Ozsaran; Aydin Ozsaran; Yilmaz Dikmen; Osman Zekioglu; Bulent Karabulut; Arif B Aras
Journal:  Med Oncol       Date:  2009-06-18       Impact factor: 3.064

6.  Metastatic patterns in histologic variants of ovarian cancer. An autopsy study.

Authors:  P G Rose; M S Piver; Y Tsukada; T S Lau
Journal:  Cancer       Date:  1989-10-01       Impact factor: 6.860

7.  Skin metastases in cancer patients.

Authors:  P S Spencer; T N Helm
Journal:  Cutis       Date:  1987-02

8.  Distant metastases in ovarian carcinoma.

Authors:  G Cormio; C Rossi; A Cazzolla; L Resta; G Loverro; P Greco; L Selvaggi
Journal:  Int J Gynecol Cancer       Date:  2003 Mar-Apr       Impact factor: 3.437

9.  Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis.

Authors:  Michael A Ströhlein; Robert Siegel; Michael Jäger; Horst Lindhofer; Karl-Walter Jauch; Markus M Heiss
Journal:  J Exp Clin Cancer Res       Date:  2009-02-14

10.  Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer.

Authors:  P Ruf; O Gires; M Jäger; K Fellinger; J Atz; H Lindhofer
Journal:  Br J Cancer       Date:  2007-07-10       Impact factor: 7.640

View more
  5 in total

1.  Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer.

Authors:  Fausto Petrelli; Karen Borgonovo; Veronica Lonati; Stefano Elia; Sandro Barni
Journal:  Target Oncol       Date:  2012-11-30       Impact factor: 4.493

2.  Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report.

Authors:  Angelika Bezan; Florian Hohla; Thomas Meissnitzer; Richard Greil
Journal:  BMC Cancer       Date:  2013-12-31       Impact factor: 4.430

Review 3.  Clinical Pharmacology and Translational Aspects of Bispecific Antibodies.

Authors:  A Trivedi; S Stienen; M Zhu; H Li; T Yuraszeck; J Gibbs; T Heath; R Loberg; S Kasichayanula
Journal:  Clin Transl Sci       Date:  2017-03-15       Impact factor: 4.689

Review 4.  Cutaneous Metastases in Ovarian Cancer.

Authors:  Isao Otsuka
Journal:  Cancers (Basel)       Date:  2019-09-02       Impact factor: 6.639

5.  Two independent incidences of skin metastases in the umbilicus and abdominal wall in ovarian serous adenocarcinoma: A case report and review of the literature.

Authors:  Hongyan Cheng; Chunmei Gao; Runtong Zhang; Zhaojie Yang; Guiyu Zhang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.